R2GConnect is the AI-powered engagement infrastructure pharma companies license, white-label and deploy to support therapy brands, generate real-world evidence, and deepen HCP relationships โ without building from scratch.
ProView delivers real-time AI patient summaries to physicians at point of care โ branded to your therapy. Keeps your brand in the HCP's daily workflow without rep visits.
White-label patient platform for adherence, education and remote monitoring. Enrol โ Monitor โ Educate โ Alert โ Report. Deployable in 60โ90 days under your brand.
Continuous biometric data streams generate publication-grade real-world evidence. AI identifies undertreated patients within provider networks eligible for your therapy.
Most pharma digital partnerships are built on a promise. Ours is built on a peer-reviewed publication. The same RWE capability that produced our Springer Nature 2024 trial is deployable for your therapy brand.
Adherence companion for Ozempic, Wegovy & metabolic therapies. Biometric monitoring + AI lifestyle guidance.
Diabetes, NAFLD, hypertension โ continuous monitoring integrated with therapy protocols.
Oral oncolytics adherence & remote toxicity monitoring. Patient-reported outcomes automated by AI.
High-touch programmes for complex specialty regimens with AI personalisation at scale.
Remote recruitment, biometric data collection and AI-driven protocol adherence monitoring.
CMS-reimbursed Remote Patient Monitoring programmes โ continuous biometric data across device types.
Let's take your therapy brand beyond the pill โ together.